Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?
Objective: To determine the time frame to the diagnosis of clinically established Parkinson’s disease (PD) or atypical parkinsonism after an acute levodopa challenge (LDC) for…The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial
Objective: This qualitative study seeks to understand how a new model of care influences a person with Parkinson’s ability to stay well physically, maintain their…Event-related oscillations in patients with Dementia with Lewy Bodies with and without mutations in the GBA gene
Objective: To explore the differences in the structure of event-related oscillations (ERO) elicited by a visual oddball task in Dementia with Lewy bodies (DLB) patients…Plasma phosphorylated α-synuclein relates to cognitive impairment in patients with Parkinson’s disease
Objective: To investigate whether plasma phosphorylated α-synuclein (p-syn) were associated with cognitive function in Parkinson’s disease (PD). Background: Parkinson’s disease (PD) is the second most…Sociodemographic, cognitive, and clinical factors explaining financial-arithmetic errors in Parkinson’s Disease
Objective: To assess the frequency, predictors, and affected cognitive representations of arithmetic errors in financial contexts in Parkinson’s Disease (PD), patients with normal cognition (PD-NC)…Facial emotion recognition and social behavioral problems in de novo parkinson’s disease patients
Objective: To examine facial emotion recognition (FER) as crucial component of social cognition and its relationship with social-behavioral problems in de novo drug-naïve Parkinson’s disease…Providing Genetic Testing and Genetic Counseling to the Parkinson’s Disease Community: the PD GENEration Pilot Study Experience
Objective: A pilot study was conducted to assess the feasibility of offering widespread genetic testing and counseling to patients with Parkinson’s disease (PD) in the…The lack of association between UQCRC1 and Parkinson’s disease in a southwest Chinese population
Objective: To further investigate the association between ubiquinol-cytochrome c reductase core protein I (UQCRC1) and Parkinson’s disease (PD) among ethnic Chinese from southwest China. Background:…The Global Parkinson’s Genetics Program (GP2) Underrepresented Populations Working Group
Objective: GP2's Underrepresented Populations Working Group (WG) was created for individuals working within underrepresented/underserved populations to join forces to increase global representation and decipher the…Comprehensive analysis of PRKN in a large Parkinson’s Disease cohort identifies causative mutations and validates population scale screening by microarray
Objective: To screen for PRKN mutations at the population scale. Background: PRKN mutations are the most common recessive cause of Parkinson’s disease (PD) and are…
- 1
- 2
- 3
- …
- 132
- Next Page »